Saenz-Ponce, Natalia <br/><br/>
Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas.  [electronic resource] 

 -  Science translational medicine  06 2018 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1946-6242 
<br/><br/><label>Standard No.: </label>10.1126/scitranslmed.aar7223  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Active Transport, Cell Nucleus--drug effects<br/>Animals<br/>Anthracyclines--pharmacology<br/>Cell Line, Tumor<br/>Cell Nucleus--drug effects<br/>Doxorubicin--pharmacology<br/>Drug Resistance, Neoplasm--drug effects<br/>E2F1 Transcription Factor--metabolism<br/>E2F7 Transcription Factor--metabolism<br/>Humans<br/>Karyopherins--antagonists & inhibitors<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Molecular Targeted Therapy<br/>Phosphotransferases (Alcohol Group Acceptor)--metabolism<br/>Receptors, Cytoplasmic and Nuclear--antagonists & inhibitors<br/>Squamous Cell Carcinoma of Head and Neck--metabolism<br/>Exportin 1 Protein